Prevalence of Helicobacter pylori in peptic ulcer patients in greater rochester, NY: Is empirical triple therapy justified?

American Journal of Gastroenterology

Volumn 93, Issue 4, 1998, Pages 574-578

  Jyotheeswaran, S ^a   Shah, A N ^a   Jin, H O ^a   Potter, G D ^a   Ona, F V ^a   Chey, W Y ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT;

ANTIBIOTIC THERAPY; ARTICLE; DUODENUM ULCER; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PEPTIC ULCER; PREVALENCE; PRIORITY JOURNAL; SEROLOGY; STOMACH BIOPSY; STOMACH ULCER; UNITED STATES;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DRUG THERAPY, COMBINATION; DUODENAL ULCER; ENDOSCOPY, DIGESTIVE SYSTEM; EUROPEAN CONTINENTAL ANCESTRY GROUP; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MIDDLE AGED; NEW YORK; PEPTIC ULCER; PYLORIC ANTRUM; RETROSPECTIVE STUDIES; SALICYLATES; STOMACH ULCER; UREASE;

EID: 0032056298     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.1998.167_b.x     Document Type: Article

References (13)

1. 1. Tatsuta M, Iishi H, Yokata Y. Effects of Helicobacter pylori infection on healing and recurrence of gastric ulcers. Am J Gastroenterol 1995; 90:406-10.
2. 2. Graham DY, Lew GM, Klein PD, et al. Effect of treatment of Helicobacter infection on the long-term recurrence of gastric or duodenal ulcer: A randomized, controlled study. Ann Int Med 1992;116:705-8.
3. 3. Tytgat GNJ. Treatments that impact favorably upon the eradication of Helicobacter pylori and ulcer recurrence. Ailment Pharmacol Ther 1994;8:359-68.
4. 4. Logan RPH, Bardhan KD, Celestin LR. Eradication of Helicobacter pylori and prevention of recurrence of duodenal ulcer: A randomized double-blind, multicenter trial of omeprazole with or without clarithromycin. Ailment Pharmacol Ther 1995;9:417-24.
5. 5. NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. JAMA 1994;272:65-9.
6. 6. Moore DS, McCabe GP. Introduction to the practice of statistics, 2nd ed. WH Freeman Publications, 1993; chapter 8:574-635.
7. 7. The EUROGAST Study Group. Epidemiology of and risk factors for Helicobacter pylori infection among 3194 asymptomatic subjects in 17 populations. Gut 1993;34:1672-6.
8. 8. Prasad S, Mathan M, Chandy G, et al. Prevalence of Helicobacter pylori in southern Indian controls and patients with gastroduodenal disease. J Gastroenterol Hepat 1994;9:501-6.
9. 9. Gill HH, Desai HG. Editorial: Helicobacter pylori and gastroduodenal disorders in India - Lessons from epidemiology. J Clin Gastroenterol 1993;16:6-9.
10. 10. Holcombe C. Helicobacter pylori: The African enigma. Gut 1992;33: 429-31.
11. 11. Greenberg PD, Koch J, Cello JP. Clinical utility and cost effectiveness of Helicobacter pylori testing for patients with duodenal and gastric ulcers. Am J Gastroenterol 1996;91:228.
12. 12. Graham DY, Malaty HM, Evans DG, et al. Epidemiology of Helicobacter pylori in an asymptomatic population in the United States. Gastroenterol 1991;100:1495-1501.
13. 13. Sprung DJ, Apter M, Allen B, et al. The prevalence of Helicobacter pylori in duodenal ulcer disease: A community based study. Am J Gastroenterol 1996;91:1926 (A169).